Related Experiment Video

Updated: Jun 25, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

The experience of beta-thalassaemiaand its prevention in Cyprus

E M Kalokairinou1

  • 1Department of Classics and Philosophy, University of Cyprus.

Medicine and Law
|February 11, 2009
PubMed

Insights

Beta-thalassaemia, a severe genetic blood disorder, nearly wiped out Cyprus

Area of Science:

  • Genetics and Hereditary Diseases
  • Hematology
  • Medical History

Context:

  • Focuses on beta-thalassaemia, a significant haemoglobinopathy.
  • Examines the historical impact of beta-thalassaemia on the island of Cyprus during the last century.
  • Highlights the near-elimination threat to the Cypriot population due to the disease.

Purpose:

  • To discuss the medical facts of beta-thalassaemia.
  • To explore the ethical and moral dilemmas faced by medical professionals, the state, and the church.
  • To analyze a historical program for the treatment and prevention of beta-thalassaemia.

Summary:

  • Details the severe hereditary nature of haemoglobinopathies and their fatal outcomes if untreated.
  • Narrates the profound impact of beta-thalassaemia on Cyprus, posing an existential threat.
  • Analyzes the complex moral landscape surrounding disease management decisions.

Impact:

  • The study concludes that the Cypriot beta-thalassaemia management program was a successful model.
  • Emphasizes that this successful model for beta-thalassaemia management is distinct from eugenics.
  • Provides insights into historical public health strategies for genetic disorders.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...